SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-025124
Filing Date
2018-10-25
Accepted
2018-10-25 16:17:07
Documents
63
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20180930.htm 10-Q 1506445
2 EX-10.1 sbph-ex101_11.htm EX-10.1 117074
3 EX-10.2 sbph-ex102_13.htm EX-10.2 37080
4 EX-31.1 sbph-ex311_6.htm EX-31.1 23508
5 EX-31.2 sbph-ex312_8.htm EX-31.2 23085
6 EX-32.1 sbph-ex321_7.htm EX-32.1 16104
  Complete submission text file 0001564590-18-025124.txt   7030289

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sbph-20180930.xml EX-101.INS 1751807
8 XBRL TAXONOMY EXTENSION SCHEMA sbph-20180930.xsd EX-101.SCH 44117
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20180930_cal.xml EX-101.CAL 46008
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20180930_def.xml EX-101.DEF 149976
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20180930_lab.xml EX-101.LAB 359097
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20180930_pre.xml EX-101.PRE 282857
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 181139087
SIC: 2834 Pharmaceutical Preparations